We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+11.19%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$495M
AUM Growth
+$42.3M
Cap. Flow
+$9.1M
Cap. Flow %
1.84%
Top 10 Hldgs %
29.63%
Holding
118
New
15
Increased
40
Reduced
35
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 31.39%
2 Technology 14.51%
3 Consumer Discretionary 12.86%
4 Industrials 12.41%
5 Financials 12.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.77T
$27.1M 5.48%
982,800
+1,380
+0.1% +$37.5K
GILD icon
2
Gilead Sciences
GILD
$166B
$16.2M 3.28%
172,268
-14,000
-8% -$1.45M
ILMN icon
3
Illumina
ILMN
$28.2B
$14.5M 2.94%
80,904
+10,075
+14% +$1.78M
ALXN
4
DELISTED
Alexion Pharmaceuticals
ALXN
$14.2M 2.87%
76,795
+1,600
+2% +$296K
SIAL
5
DELISTED
SIGMA - ALDRICH CORP
SIAL
$14.1M 2.86%
103,050
+28,300
+38% +$3.85M
MCK icon
6
McKesson
MCK
$98.1B
$12.9M 2.6%
61,925
-7,000
-10% -$1.42M
MAR icon
7
Marriott International
MAR
$96.4B
$12.3M 2.49%
157,700
+900
+0.6% +$66.4K
ABBV icon
8
AbbVie
ABBV
$448B
$12.3M 2.48%
187,287
+18,600
+11% +$1.17M
AGN
9
DELISTED
Allergan plc
AGN
$11.7M 2.37%
+45,570
New +$11.4M
HSIC icon
10
Henry Schein
HSIC
$9.86B
$11.1M 2.25%
208,769
+15,045
+8% +$749K
EXAS
11
DELISTED
Exact Sciences
EXAS
$10.9M 2.2%
396,900
+38,000
+11% +$925K
NKE icon
12
Nike
NKE
$64.2B
$10.1M 2.04%
209,900
+108,500
+107% +$5.09M
SRCL
13
DELISTED
Stericycle Inc
SRCL
$10.1M 2.04%
76,851
+35,500
+86% +$4.47M
DFS
14
DELISTED
Discover Financial Services
DFS
$9.86M 1.99%
150,600
-34,600
-19% -$2.22M
COR icon
15
Cencora
COR
$59.6B
$9.58M 1.94%
106,300
+8,500
+9% +$729K
WFC icon
16
Wells Fargo
WFC
$263B
$9.15M 1.85%
166,850
-51,000
-23% -$2.7M
MGA icon
17
Magna International
MGA
$18.2B
$9.1M 1.84%
167,500
+11,800
+8% +$597K
ALL icon
18
Allstate
ALL
$65.2B
$8.79M 1.78%
125,100
+400
+0.3% +$26.3K
ATO icon
19
Atmos Energy
ATO
$29.5B
$8.6M 1.74%
154,300
-6,300
-4% -$332K
BIIB icon
20
Biogen
BIIB
$30B
$7.77M 1.57%
22,885
-1,525
-6% -$493K
TQNT
21
DELISTED
TRIQUINT SEMICONDUCTOR INC
TQNT
$7.32M 1.48%
265,600
+71,900
+37% +$1.6M
V icon
22
Visa
V
$687B
$7.32M 1.48%
111,600
+22,800
+26% +$1.37M
GMCR
23
DELISTED
KEURIG GREEN MTN INC
GMCR
$7.29M 1.47%
55,050
-11,773
-18% -$1.67M
DHR icon
24
Danaher
DHR
$143B
$6.98M 1.41%
121,110
+6,547
+6% +$355K
PNC icon
25
PNC Financial Services
PNC
$99.5B
$6.73M 1.36%
73,800
+4,300
+6% +$373K

Similar funds

De Burlo Group's Q4 2014 Portfolio in Review

As of Q4 2014, De Burlo Group held 118 positions worth $495M, up 9.3% from $452M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

De Burlo Group's Q4 2014 filing shows 15 new, 40 increased, 35 reduced and 11 closed positions. Its largest new stake was Allergan plc: 45,570 shares worth $11.7M. The largest sale was Alphabet (Google) Class C, an estimated $11.4M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

  • De Burlo Group's largest Q4 2014 buy was Allergan plc: 45,570 shares worth $11.7M.
  • De Burlo Group added most to Nike in Q4 2014, an estimated $5.09M increase.
  • De Burlo Group's biggest Q4 2014 reduction was SALIX PHARMACEUTICALS LTD DEL, cutting an estimated $9.56M.
  • De Burlo Group fully exited Alphabet (Google) Class C in Q4 2014, selling an estimated $11.4M.
  • De Burlo Group's ten largest holdings make up 30% of its $495M portfolio in Q4 2014.
  • De Burlo Group opened 15 new positions and closed 11 in Q4 2014.
  • De Burlo Group's portfolio value rose 9.3% quarter-over-quarter to $495M.

Based on De Burlo Group's 13F filing for Q4 2014, filed 12 Feb 2015.